abstract |
The present technology generally relates to the preparation of immunoglobulin-related compositions (eg, antibodies or antigen-binding fragments thereof) that specifically bind STEAP1 proteins and uses of such immunoglobulin-related compositions. In particular, the present technology relates to the preparation of STEAP1-binding antibodies and their use in the detection and treatment of STEAP1-related cancers. |